Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1, a minor metadata update that does not affect study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice banner was removed from the page, while the study details and links remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedResults for the study have been posted on the page, with Results First Posted dates in January and February 2025. The results section includes primary and secondary outcomes such as CD8+ T cell density in tumor tissue and the pathologic complete response rate.SummaryDifference0.4%

- Check71 days agoChange DetectedThe page has been updated to announce a new version (v3.2.0) and to clarify government operating status and potential processing delays; the previous version tag (v3.1.0) has been removed.SummaryDifference4%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.